Abnormal endothelial NO vasodilator mechanisms contribute to increased cardiovascular risk in the aging cardiovascular system. L-arginine, the NO synthase substrate, improves endothelial dependent vasodilatation by unknown mechanism(s), since intracellular concentrations of L-arginine far exceed the Kd for nitric oxide synthase (NOS). The observation that L-arginine administration increases NO synthesis and enhances endothelial function even in the setting of apparently adequate L-arginine levels in the cell has come to be called the """"""""L-arginine paradox"""""""". Arginase, an enzyme of the urea cycle also uses L-arginine as a substrate and is present in cardiovascular tissue. Our preliminary data demonstrate that the L-arginine metabolizing enzyme, arginase, reciprocally regulates vascular endothelial NOS activity, and directly influences vascular relaxation in rats. Furthermore, arginase activity and expression are increased in agingrat vessels, and arginase inhibition attenuates the increased reactive oxygen species (ROS) produced in old rat vascular tissue. We hypothesize that: 1) endothelial arginase limits endothelial NO production and thus, endothelial-dependent vasodilatation, by competing for intracellular L-arginine; 2) vascular endothelial dysfunction of aging is associated with increased expression of endothelial arginase, and inhibition of arginase restores NO-dependent signaling and endothelial function to that of the young phenotype; 3) relative substrate (L-arginine) deficiency enhances ROS production further compromising endothelial function by altering the balance between NO and 02-; and 4) chronic arginase inhibition will restore Larginine reponsiveness, enhance NO signaling, and decrease ROS production thereby restoring altered integrated cardiovascular parameters (increased vascular and ventricular stiffness and altered ventriculararterial coupling) to that of the young phenotype. We will study the regulatory role of arginase in normal endothelial function and NO signaling, as well as its role in the pathophysiology of endothelial dysfunction associated with aging. These experiments will offer novel insights into regulation of the NO signaling pathway, and the balance between NO and 02- in endothelial function, with important therapeutic implications for a wide variety of disorders characterized by endothelial dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG021523-05
Application #
7263878
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Kohanski, Ronald A
Project Start
2003-08-15
Project End
2009-07-31
Budget Start
2007-08-01
Budget End
2009-07-31
Support Year
5
Fiscal Year
2007
Total Cost
$387,569
Indirect Cost
Name
Johns Hopkins University
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Steppan, Jochen; Tran, Huong T; Bead, Valeriani R et al. (2016) Arginase Inhibition Reverses Endothelial Dysfunction, Pulmonary Hypertension, and Vascular Stiffness in Transgenic Sickle Cell Mice. Anesth Analg 123:652-8
Frank, Steven M; Abazyan, Bagrat; Ono, Masahiro et al. (2013) Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg 116:975-81
Khan, Mehnaz; Steppan, Jochen; Schuleri, Karl H et al. (2012) Upregulation of arginase-II contributes to decreased age-related myocardial contractile reserve. Eur J Appl Physiol 112:2933-41
Barodka, Viachaslau M; Joshi, Brijen L; Berkowitz, Dan E et al. (2011) Review article: implications of vascular aging. Anesth Analg 112:1048-60
Ryoo, Sungwoo; Bhunia, Anil; Chang, Fumin et al. (2011) OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis 214:279-87
Dunn, Jessilyn; Gutbrod, Sarah; Webb, Alanah et al. (2011) S-nitrosation of arginase 1 requires direct interaction with inducible nitric oxide synthase. Mol Cell Biochem 355:83-9
Yang, Ronghua; Sikka, Gautam; Larson, Jill et al. (2011) Restoring leptin signaling reduces hyperlipidemia and improves vascular stiffness induced by chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol 300:H1467-76
White, Anthony R; Ryoo, Sungwoo; Bugaj, Lukasz et al. (2010) Early changes in vasoreactivity after simulated microgravity are due to an upregulation of the endothelium-dependent nitric oxide/cGMP pathway. Eur J Appl Physiol 110:395-404
Gregg, Christopher J; Steppan, Jochen; Gonzalez, Daniel R et al. (2010) ?2-adrenergic receptor-coupled phosphoinositide 3-kinase constrains cAMP-dependent increases in cardiac inotropy through phosphodiesterase 4 activation. Anesth Analg 111:870-7
Sikka, G; Yang, R; Reid, S et al. (2010) Leptin is essential in maintaining normal vascular compliance independent of body weight. Int J Obes (Lond) 34:203-6

Showing the most recent 10 out of 30 publications